In the first half of 2024, Belgian tech start-ups attracted nearly €470 million, surpassing the 2023 annual total of €424 million. This acceleration masks a mixed picture: foreign investors have accounted for an average of 66% of funding since 2020, but the amounts raised vary widely depending on the company’s stage of maturity and sector. Assessing Belgium’s appeal means distinguishing highly visible large deals from the ecosystem’s underlying momentum.
Funding distribution in Belgium: company stage and source of capital
| Stage | Recent trend | Investor profile |
|---|---|---|
| Seed/early-stage funding | Strong rebound in 2024 | Mostly local funds, with occasional participation from European funds |
| Growth capital | Slight decline from the 2021 peak | Foreign investors more active in larger rounds |
| Late stage / pre-IPO | Concentrated in a handful of deals | International and non-traditional funds (corporate VCs, family offices) |
This table highlights an imbalance. The rebound in seed funding shows that the ecosystem remains fertile ground for launching new companies. However, international investors focus on large transactions, those worth tens of millions of euros or more.
At the European level, Belgium ranks eleventh for amounts raised between 2020 and 2026. The Nordic countries and the Netherlands attract proportionally more venture capital. Belgian tech outside biotech also raised less in 2025 than in 2024, showing that the trend is not uniformly upward.
In practice, Belgian start-ups attract foreign investors mainly when they operate in niches where Belgium has a recognized competitive advantage. Outside these niches, funding is harder to secure.

Biotech, healthcare and ICT: sector specialisation attracts foreign capital
Belgian venture capital is heavily concentrated in biotech, healthcare and information technology. This specialisation largely explains the interest from foreign funds. Belgium has renowned research universities, active university spin-offs and a regulatory environment conducive to clinical trials.
International investors do not come “for Belgium” in general. They target companies whose fields align with their investment theses. A Walloon start-up applying artificial intelligence to healthcare or a Flemish cybersecurity scale-up benefits from leverage that a young e-commerce or business services company does not.
What this concentration means for the rest of the ecosystem
Less capital-intensive sectors (B2B SaaS, niche fintech and early-stage cleantech) struggle to attract the attention of major funds. Founders in these fields turn to local investors or regional public programmes, which offer smaller tickets.
- Biotech accounts for most rounds exceeding €20 million, inflating the ecosystem’s overall figures
- Artificial intelligence is attracting increasing amounts of capital, but investment remains concentrated in a handful of large deals
- Start-ups in traditional digital services raise comparatively small amounts, often only at seed or Series A stage
Belgium’s appeal is sector-specific before it is national. Looking at aggregate figures without distinguishing between sectors gives a distorted picture of reality.
Foreign capital and local roots: who holds decision-making power?
Foreign funds taking a stake in a Belgian start-up is not a neutral development. Beyond providing capital, they can change governance, strategic priorities and, sometimes, the location of key functions.
When a US or British fund leads a Series B or C round, it often sets conditions: a board based in an Anglo-Saxon jurisdiction, the recruitment of a CEO with an international profile, and preparation for an exit (acquisition or IPO) in a foreign market. Capital flows into Belgium, but the value created may flow out.
Examples of relocation
Several Belgian scale-ups that raised substantial sums from foreign investors have moved their operational headquarters or commercial leadership to London, Amsterdam or New York. This makes sense in terms of market access, but raises a question for the local ecosystem: do skilled jobs, intellectual property and tax revenues follow the capital?
Belgium’s institutional fragmentation, with three regions pursuing distinct economic policies, makes a coordinated response to this phenomenon more difficult. There is no unified federal strategy that makes public support conditional on keeping a company’s headquarters in Belgium when foreign investors come on board.

Talent shortages and regional fragmentation: structural barriers to watch
The “State of Belgian Tech 2024” report (produced by Syndicate One, Bain & Company and Sofina) identifies talent shortages as a major challenge. Attracting capital is not enough if companies cannot find the developers, data scientists and managers needed to drive growth.
Regional disparities make the problem worse. Flanders accounts for most fundraising, Brussels attracts international talent, and Wallonia has underused research potential. This cultural and geographical fragmentation scatters efforts instead of bringing them together.
- Belgium’s high labour costs weaken its competitive edge against hubs in Eastern or Southern Europe for technical roles
- Belgian universities produce top-tier researchers, but fewer go on to become entrepreneurs than in the Nordic countries
- Regional incubation programmes operate in silos, with no systematic links between Wallonia, Flanders and Brussels
Attracting foreign investors also depends on the ability to retain talent after funding has been secured. A Series A round is worthless if the technical team moves to Amsterdam six months later.
Belgium is producing promising start-ups and attracting a growing share of foreign capital, driven by a handful of areas of excellence. The figure that matters is not the total amount raised, but the share of that value that remains rooted in the country: jobs, patents and decision-making headquarters. By that measure, the picture is more nuanced than the aggregate figures suggest.



